Welcome to our dedicated page for CORVEL SEC filings (Ticker: CRVL), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
CorVel Corporation's SEC filings document the company's public-company reporting for a technology-enabled risk management business serving workers' compensation and health, auto, and liability programs. Recent 8-K filings furnish quarterly financial results through Item 2.02 disclosures and related earnings press releases.
CorVel's proxy and annual meeting filings cover stockholder voting matters, director elections, auditor ratification, and governance procedures. The filings also identify the company's common stock, par value $0.0001 per share, traded under CRVL on the Nasdaq Global Select Market, tying its governance record to its listed equity security.
CorVel Corp CEO & President Michael G. Combs reported multiple stock option exercises and related share withholdings dated January 5, 2026. He exercised non-qualified stock options covering 27,750, 501 and 156 shares of common stock at exercise prices of $51.997, $39.827 and $34.437 per share, respectively. According to the footnote, shares were delivered to pay the option exercise price and/or tax liabilities incident to these exercises, including transactions where 21,175 and 2,306 shares of common stock, among smaller amounts, were withheld. After these transactions, he directly owned 48,773 shares of common stock and 22,871 non-qualified stock options.
CorVel Corp director Steve Hamerslag reported a charitable gift of 7,000 shares of common stock on 12/11/2025. The transaction was coded as a gift and carried a reported price of $0.0 per share, indicating it was not a market sale.
After this donation, Hamerslag beneficially owns 307,000 CorVel shares directly. The footnote explains that the shares were gifted to charity DAFgiving360.
CorVel Corporation (CRVL) director stock sale reported. A company director reported selling 3,247 shares of CorVel common stock on 11/07/2025 in an open-market transaction coded "S" for sale. The weighted average sale price was $76.20 per share, with individual trades executed between $76.10 and $76.27. After this transaction, the reporting person beneficially owns 111,798 CorVel shares in direct ownership.
CorVel Corp (CRVL) executive vice president for Risk Management Services, Mark Bertels, reported an insider transaction involving company stock. On 11/19/2025, he exercised a non-qualified stock option to buy 1,200 shares of common stock at an exercise price of $34.437 per share, then sold 1,200 shares of common stock at a price of $72.35 per share on the same date. After these transactions, he directly owns 2,594 shares of CorVel common stock and holds no remaining derivative securities from this option grant. The option was originally structured to vest 25% one year after grant with the balance vesting in 36 equal monthly installments.
CorVel (CRVL) director reported open‑market sales on a Form 4. On 11/10/2025, 210 shares of common stock were sold at $76.27, leaving 122,121 shares beneficially owned directly. On 11/11/2025, a further 7,076 shares were sold at $76.94, bringing direct beneficial ownership to 115,045 shares.
The filing indicates a single reporting person and direct ownership of all reported holdings.
CorVel Corp (CRVL) reported a Form 4 for Vice President of Accounting Jennifer Yoss. On 11/06/2025, she was granted 3,500 non‑qualified stock options with an exercise price of $75.36, expiring on 11/06/2030.
The options will vest based on achievement of performance criteria relating to earnings growth. Following the grant, she beneficially owned 3,500 derivative securities held directly.
CorVel Corp (CRVL) disclosed that Chief Information Officer Maxim Shishin received a performance-based non-qualified stock option grant. The award covers 4,000 options with an exercise price of $75.36, granted on 11/06/2025 and expiring on 11/06/2030. Vesting is tied to achieving certain performance criteria relating to earnings growth. The filing lists the ownership of the derivative securities as direct.
CorVel (CRVL) reported an insider equity grant. The company’s EVP of Risk Management Services received a non-qualified stock option for 4,000 shares at an exercise price of $75.36 on 11/06/2025, coded “A” for award. The option expires on 11/06/2030 and vests based on achieving performance criteria related to earnings growth. Following the grant, 4,000 derivative securities were beneficially owned, held directly.
CorVel Corporation filed a Form S-8 registering 1,775,459 shares of common stock for issuance under the CorVel Corporation 2025 Stock Incentive Plan. The plan was approved by stockholders on August 7, 2025. This registration supports equity-based compensation, allowing the company to grant options and other awards to employees, directors, and eligible participants under the plan.
Form S-8 registrations are administrative and do not, by themselves, represent a capital raise or a public sale. Instead, they make plan shares available for future grants consistent with the plan’s terms and applicable securities laws.
CorVel Corporation reported stronger quarterly results for the three months ended September 30, 2025. Revenue reached $239,643,000, up 7% year over year, as network solutions activity expanded with existing customers. Net income was $27,906,000 and diluted EPS was $0.54, compared with $0.45 a year ago.
Profitability improved: gross margin rose to 24.3% from 22.6%, while general and administrative costs held near 9% of revenue. Segment mix was 62.9% patient management ($150,795,000) and 37.1% network solutions ($88,848,000). Operating cash flow for the first six months totaled $80,035,000, supporting cash and equivalents of $207,453,000.
The company continued buybacks, repurchasing 143,774 shares for approximately $12.8 million in the quarter and 230,879 shares for $22.5 million year-to-date. Shares outstanding were 51,293,374 as of September 30, 2025. Management also noted a recent technology asset acquisition to enhance bill review capabilities.